• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Oncology
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Oncology
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

M&A

Sanofi continues tweaks to executive roster as new CEO Garijo settles in
Pharma

Sanofi announces limited changes to its revamped executive team

With former Merck KGaA CEO Belén Garijo now calling the shots at Sanofi, the French pharma continues to refine its executive roster.
Fraiser Kansteiner Jul 21, 2026 1:35pm
A chessboard with blocks that read MA

Vertex to pay $10B for Crinetics in its largest-ever deal

Jul 7, 2026 8:08am
Horseshoe magnet attracting metallic pawn people

Kimball makes $103M bid to grow its CDMO footprint in EU, India

Jul 1, 2026 10:22am
A chessboard with blocks that read MA

After trial fail, Teravance is bought out by Zymeworks for $929M

Jun 29, 2026 11:30am
Fosun

Fosun Pharma plots global push, fueled by Alzheimer’s deals

Jun 25, 2026 7:00pm
Four large while puzzle pieces are being connected together on a dark brown table by four sets of hands

Merck KGaA charts biggest deal in 10+ years with Bio-Techne buy

Jun 25, 2026 9:56am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings